NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease

Abstract

This study provides a new theoretical basis for innate immune participation in atherosclerosis development and highlights the potential of the NLRP3 inflammasome as a target for prevention and treatment of CAD.